The prevalence of depression in the UK has led to a significant rise in antidepressant prescriptions, raising concerns among healthcare professionals about the long-term impact on patients.
A recent study has unveiled new insights into the mechanisms underlying ketamine's rapid antidepressant effects, suggesting a significant role for the complement system.
Monoamine oxidase inhibitors commonly prescribed to treat depression; medications work by boosting levels of serotonin, the brain's 'happiness hormone'.